Advanced search
Publication Cover
Cancer Investigation Volume 23, 2005 - Issue 5
Submit an article Journal homepage
68
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Phase II Study of Gemcitabine Plus Paclitaxel in Metastatic Breast Cancer Patients with Prior Anthracycline Exposure

Mutlu Demiray Uludag University Medical School, Bursa, TurkeyCorrespondence[email protected]
,
Ender Kurt Uludag University Medical School, Bursa, Turkey
,
Turkkan Evrensel Uludag University Medical School, Bursa, Turkey
,
Ozkan Kanat Uludag University Medical School, Bursa, Turkey
,
Murat Arslan Uludag University Medical School, Bursa, Turkey
,
Ozlem Saraydaroglu Uludag University Medical School, Bursa, Turkey
,
Ilker Ercan Uludag University Medical School, Bursa, Turkey
,
Guzin Gonullu Uludag University Medical School, Bursa, Turkey
,
Sehsuvar Gokgoz Uludag University Medical School, Bursa, Turkey
,
Ugur Topal Uludag University Medical School, Bursa, Turkey
,
Sahsine Tolunay Uludag University Medical School, Bursa, Turkey
,
Ismet Tasdelen Uludag University Medical School, Bursa, Turkey
&
Osman Manavoglu Uludag University Medical School, Bursa, Turkey
 show all
Pages 386-391 | Published online: 11 Jun 2009

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Erin M Bertino & Bhuvaneswari Ramaswamy. (2010) Ixabepilone as monotherapy or in combination for the treatment of advanced breast cancer. Breast Cancer: Targets and Therapy 2, pages 13-23.
Read now

Articles from other publishers (8)

J. Salvador, L. Manso, J. de la Haba, A. Jaen, E. Ciruelos, M. C. de Villena, M. Gil, A. Murias, A. Galan, C. Jara, J. Bayo, J. M. Baena, J. Casal, J. R. Mel, I. Blancas & P. Sanchez Rvira. (2014) Final results of a phase II study of paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer. Clinical and Translational Oncology 17:2, pages 160-166.
Crossref
Binghe Xu, Zefei Jiang, Sung-Bae Kim, Shiying Yu, Jifeng Feng, Artur Malzyner, Auro del Giglio, Hyun C. Chung, Li Jun Shen & Daniel Lee Kay Pen. (2011) Biweekly gemcitabine–paclitaxel, gemcitabine–carboplatin, or gemcitabine–cisplatin as first-line treatment in metastatic breast cancer after anthracycline failure: a phase II randomized selection trial. Breast Cancer 18:3, pages 203-212.
Crossref
Kenjiro Aogi, Masayuki Yoshida, Yoshiaki Sagara, Shunji Kamigaki, Minoru Okazaki, Jumpei Funai, Toshio Fujimoto, Masakazu Toi, Toshiaki Saeki & Shigemitsu Takashima. (2010) The efficacy and safety of gemcitabine plus paclitaxel combination first-line therapy for Japanese patients with metastatic breast cancer including triple-negative phenotype. Cancer Chemotherapy and Pharmacology 67:5, pages 1007-1015.
Crossref
Binghe XU, Zhenzhou SHEN, Zefei JIANG, Zhongzhen GUAN & Xiaoqing ZHANG. (2010) A phase II study of gemcitabine plus paclitaxel in patients with metastatic breast cancer and prior anthracycline treatment. Asia-Pacific Journal of Clinical Oncology 6:4, pages 320-329.
Crossref
Keun Seok Lee, Jungsil Ro, Eun Sook Lee, Han Sung Kang, Seok Won Kim, Byung-Ho Nam, Youngmee Kwon, Eun-A Kim & Kyung Hwan Shin. (2009) Primary systemic therapy with intermittent weekly paclitaxel plus gemcitabine in patients with stage II and III breast cancer: a phase II trial. Investigational New Drugs 28:1, pages 83-90.
Crossref
Kathy S. AlbainShona M. NagGerman Calderillo-RuizJohann P. JordaanAntonio C. LlombartAnna PluzanskaJanusz RolskiAllen S. MelemedJose M. Reyes-VidalJagdev S. SekhonLorinda SimmsJoyce O'Shaughnessy. (2008) Gemcitabine Plus Paclitaxel Versus Paclitaxel Monotherapy in Patients With Metastatic Breast Cancer and Prior Anthracycline Treatment. Journal of Clinical Oncology 26:24, pages 3950-3957.
Crossref
J. Aubrey Waddell & Dominic A. SolimandoJrJr. (2017) Paclitaxel and Gemcitabine (PG) for Advanced Breast Cancer. Hospital Pharmacy 42:6, pages 510-516.
Crossref
Ali I. Shamseddine, Zaher K. Otrock, Mohamad J. Khalifeh, Hanan R. Yassine, Maya Charafeddine, Zeina Abdel-Khalek, Aref Chehal, Nizar Bitar, Rahif Jalloul, Moussa Dheiny, Azzam Dandashi, Mahmoud Wehbeh & Nagi S. El-Saghir. (2006) A Clinical Phase II Study of a Non-Anthracycline Sequential Combination of Cisplatin-Vinorelbine Followed by Docetaxel as First-Line Treatment in Metastatic Breast Cancer. Oncology 70:5, pages 330-338.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.